We and our affiliates and vendors use cookies and similar technologies to operate our sites, recognize visitors to our sites, provide secure log-in, collect statistics to optimize site functionality, and deliver content tailored to your interests. Click Accept All to accept all cookies and go directly to the site, click Reject All to reject all but cookies strictly necessary to the functioning of this site (required cookies), or click on Manage Settings to see detailed descriptions of the types of cookies and choose whether to accept certain cookies while on the site.
Simplify your Neurology Diagnostic Testing with the Freelite Mx™ Kappa Assay
The optimised workflow solution to evaluate intrathecal immunoglobulin synthesis
Evaluate intrathecal immunoglobulin synthesis with the Freelite Mx Kappa Assay
Intrathecal immunoglobulin synthesis has been observed in various neurological disorders, such as Multiple Sclerosis1.
The traditional approach for the evaluation of intrathecal immunoglobulin synthesis is detection of CSF-restricted oligoclonal IgG bands (OCB)2.
OCB is a specialised gel-based technique that requires highly skilled operators to interpret.
Even when experienced professionals interpret the results, inter-laboratory and inter-observer variability can be observed3.
“[…] one of the clear advantages of кFLC is the reliable and rater-independent determination, which should overcome technical difficulties and finally allow a widespread use.”
Hegen, Multiple Sclerosis 20224
The Freelite Mx Kappa assay measures Kappa Free Light Chain (FLC) concentration in CSF, run on the Optilite® automated analyser.
CSF Kappa FLC measurement is recognised as interchangeable with OCB when used as an aid in the diagnosis of Multiple Sclerosis5.
The laboratory process for evaluating intrathecal immunoglobulin synthesis can be simplified by the use of Freelite Mx assays run on the Optilite analyser.
Transform your diagnostic testing with the Optilite Analyser
Operator independent
Quantitative
Fully automated
Download this analytical brochure
Find out how you can simplify your neurology diagnostic testing with Freelite Mx Kappa assay on the Optilite analyser
Freelite Mx Kappa assay is used to calculate Kappa Index
Intrathecal synthesis of immunoglobulins is a hallmark of Multiple Sclerosis2. An elevated Kappa Free Light Chain (FLC) concentration in CSF indicates intrathecal immunoglobulin synthesis3.
An impaired blood-CSF barrier can also cause Kappa FLC to appear in CSF, so the origin of CSF Kappa FLCs needs to be identified4.
Calculations that involve CSF/serum Kappa FLC and CSF/serum albumin quotients, such as Kappa Index, help differentiate whether the Kappa FLCs have been intrathecally synthesized or are derived from serum3.
In cases where CSF albumin is also elevated, increases in CSF Kappa FLC are unlikely to be due to intrathecal synthesis, as increased CSF albumin indicates an impaired blood-brain barrier3.
There is a good overall agreement between Kappa Index results and the absolute CSF Kappa FLC level. However, Kappa Index appears superior in cases of low or modest intrathecal production of Kappa FLCs3.
Is your laboratory ready?
Hear a neurologist's perspective
Download clinical brochure
Find out more about the diagnostic performance of Kappa Index to aid in the diagnosis of Multiple Sclerosis
Discover the complete solution for CSF analysis on the Optilite special protein analyser
- An assay panel that can aid in the characterization of intrathecal immunoglobulin synthesis, blood brain-barrier dysfunction and in the diagnosis of infection and inflammation of the central nervous system.
Generate results to calculate CSF/Serum ratios, using assays designed to measure both CSF and serum samples using a single instrument.
Discover the full range of assays on the Optilite Analyser
Related content
References
- Carta S, et al. Oligoclonal bands: clinical utility and interpretation cues. Crit Rev Clin Lab Sci 2022; 1-14
- Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17:162-173
- Hegen H, et al. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement. Mult Scler 2022; 29:182-195
- Hegen H, et al. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis. Mult Scler 2022; 29:169-181
- ECTRIMS. McDonald Diagnostic Criteria. 2024 [02/2025]; Available from: https://ectrims.eu/mcdonald-diagnostic-criteria.
Contact Us?
Questions about our products or services? Our team is ready to hear them.